ÂÎÇÌÎÆÍÎÑÒÈ ÎÄÍÎÔÎÒÎÍÍÎÉ ÝÌÈÑÑÈÎÍÍÎÉ ÊÎÌÏÜÞÒÅÐÍÎÉ ÒÎÌÎÃÐÀÔÈÈ Â ÎÖÅÍÊÅ ÑÈÌÏÀÒÈ×ÅÑÊÎÉ ÀÊÒÈÂÍÎÑÒÈ ÌÈÎÊÀÐÄÀ Ó ÁÎËÜÍÛÕ Ñ ÏÎÑÒÎßÍÍÎÉ ÔÈÁÐÈËËßÖÈÅÉ ÏÐÅÄÑÅÐÄÈÉ

Àííîòàöèÿ
îÿííîé ôèáðèëëÿöèåé ïðåäñåðäèé, îáñëåäîâàíû 20 áîëüíûõ, ñðåäíèé âîçðàñò êîòîðûõ ñîñòàâèë 69,2±8,3 ãîäà (îò 62 äî 78 ëåò) è 14 ïðàêòè÷åñêè çäîðîâûõ ëèö (ñðåäíèé âîçðàñò 45,85±2,67 ëåò).

Annotation
To study the sympathetic myocardial innervation in coronary artery disease patients with chronic atrial fibrillation, 20 patients aged 69.2±8.3 years (62 78 years) and 14 healthy subjects aged 45.85±2.67 years were examined.


Àâòîð
Ãðèøàåâ, Ñ. Ë., Òêà÷åíêî, Ê. Í., Ñâèñòîâ, À. Ñ., Ñóõîâ, Â. Þ., Íèêèôîðîâ, Â. Ñ.

Íîìåðà è ðóáðèêè
ÂÀ-N63 îò 22/06/2011, ñòð. 12-14